BIZARRO SPRAY OPTIONS

lorlatinib will decrease the extent or outcome of ergotamine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Keep away from usage of lorlatinib with CYP3A substrates, where nominal concentration variations could produce severe therapeutic failures of your substrate.Contraindicated. "Opportunity for cr